Single Source Procurement: Sickle Cell Reagent Test Kits

Pursuant to New York State Finance Law § 163.10(b), The New York State Department of Health is presenting the following summary of relevant circumstances, and material and substantial reasons why a competitive procurement was not feasible. Bio-Rad’s VARIANT™nbs Sickle Cell program is currently the ONLY FDA approved under Sec. 864.7415, Abnormal hemoglobin assay, inclusive of an HPLC system device, software and testing reagents. (FDA 510(k) # K080911).

Procurement / Program Name Sickle Cell Reagent Test Kits
Contractor Name(s) Bio-Rad Laboratories, Inc.
Contract Period 10/1/18- 9/3/23
Contract Number PA32230